SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals,
Inc. (Amex: ANX) today announced that Evan M. Levine, ADVENTRX's Chief
Executive Officer and President, is scheduled to present at the Rodman &
Renshaw 5th Annual Global Healthcare Conference. Mr. Levine is scheduled to
present on Tuesday, May 20, 2008 at 2:00 p.m. Central European Summer Time
in the Atlantique Salon (8:00 a.m. Eastern Daylight Time). The conference
takes place May 19 - 20, 2008 at the Le Meridien Beach Plaza Hotel, in
Monte Carlo, Monaco.
The presentation will be webcast live and available for replay via the
"Investors" section of the Company's web site at http://www.adventrx.com
under "Events." The webcast will be made available for replay for 14 days
and can be accessed through the same link.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on
in-licensing, developing and commercializing proprietary product candidates
primarily for the treatment of cancer and infectious disease. The Company
seeks to improve the performance and commercial potential of existing
treatments by addressing problems associated with these treatment regimens.
More information can be found on ADVENTRX's web site at
http://www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.
 back to top
Related links:
http://www.adventrx.com/
CONTACT:
Investors, Ioana C. Hone of ADVENTRX
Pharmaceuticals, +1-858-552-0866
|
